During the ERS 2019 two posters were presented on the deposition of extrafine vs. non-extrafine formulations of different respiratory drugs in different inhalation devices.
Both studies were conducted with Functional Respiratory Imaging (FRI) technology, a very sensitive tool to track deposition in the lungs.
Benjamin Mignot, Lead Project Engineer at Fluidda , talks about the differences found between both formulations in amount and location of deposition of particles.
This study was made in collaboration with https://www.chiesi.be/
Deposition, ERS, ICS, LABA, Particles